Atlas Trials

Impact of Daridorexant on Sleep, Daytime Alertness, and Smoking

Clinical trial NCT07328594 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07328594
Sponsor
Legacy Health System
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
SmokingNicotineTobaccoAddictionSubstance Use DisordersInsomniaSleep
Start date
2026-02-10
Primary completion
2027-03-31
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.